Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kavanagh

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancerTracey E Schefter, Brian D Kavanagh, Qiuwen Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2008
Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomasAmanda L Schwer, Brian D Kavanagh, Robert McCammon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic ablative radiotherapy: what's in a name?Billy W Loo, Joe Y Chang, Laura A Dawson, et al.
Seminars in Radiation Oncology|July 16, 2002
Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancerBrian D Kavanagh, Tracey E Schefter, Qiuwen Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the stomach and small bowelBrian D Kavanagh, Charlie C Pan, Laura A Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation-associated liver injuryCharlie C Pan, Brian D Kavanagh, Laura A Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatmentsQuentin Diot, Lawrence B Marks, Soren M Bentzen, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|January 28, 2014
Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinibGregory N Gan, Andrew J Weickhardt, Benjamin Scheier, et al.
Journal of Neuro-Oncology|June 5, 2013
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomideKrishna Reddy, Laurie E Gaspar, Brian D Kavanagh, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 21, 2002
Technical considerations in the application of intensity-modulated radiotherapy as a concomitant integrated boost for locally-advanced cervix cancerTracey E Schefter, Brian D Kavanagh, Qiuwen Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2008
Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomasAmanda L Schwer, Brian D Kavanagh, Robert McCammon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 2, 2010
Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomasEmma C Fields, Denise Damek, Laurie E Gaspar, et al.
Practical Radiation Oncology|March 29, 2014
Stereotactic ablative radiotherapy: what's in a name?Billy W Loo, Joe Y Chang, Laura A Dawson, et al.
Seminars in Radiation Oncology|July 16, 2002
Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancerBrian D Kavanagh, Tracey E Schefter, Qiuwen Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the stomach and small bowelBrian D Kavanagh, Charlie C Pan, Laura A Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation-associated liver injuryCharlie C Pan, Brian D Kavanagh, Laura A Dawson, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2014
Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatmentsQuentin Diot, Lawrence B Marks, Soren M Bentzen, et al.
Pageof 15